OCT Angiography Findings in Preclinical Alzheimer’s Disease: 3-Year Follow-Up

Preclinical Alzheimer’s disease (AD) is a recognized disease stage in which amyloid begins to accumulate within the central nervous system before the onset of disease symptoms. Preclinical AD is diagnosed by measuring amyloid burden either by neuroimaging with amyloid markers or by direct measurement within cerebrospinal fluid (CSF). 1 Roe C.M. Fagan A.M. Grant E.A. et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up...